Newsletter registration

Austria.
Where Great Emphasis is Put on Research.

New IMP building: International research center opens in Vienna

opening ceremony at IMP © IMP

Philipp von Lattorff explains that Boehringer Ingelheim, in its capacity as a family-owned company, has the financial means to support basic research which may first lead to the development of new drugs in the long run. “IMP is the most important investment of Boehringer Ingelheim in basic research”, says the Managing Director of Boehringer Ingelheim RCV.

About IMP

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by the international Boehringer Ingelheim group of companies With over 200 scientists from 40 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms in order to provide detail knowledge of complex biological phenomena. The IMP is a founding member of the Vienna Biocenter, Austria’s beacon in the international elite of top molecular-biological research.

About Boehringer Ingelheim Regional Center Vienna

The Boehringer Ingelheim Regional Center Vienna is responsible for Boehringer Ingelheim’s business with prescription drugs and animal medicines in Austria and over 30 other countries in Central and Eastern Europe, Central Asia, Switzerland and Israel. Moreover, the entire clinical research of the region is managed from Vienna. Vienna is the center for cancer research and also a location for biopharmaceutical research, development and production in the Group. Boehringer Ingelheim is also involved in basic research and is represented in this field by the Research Institute of Molecular Pathology Vienna (IMP). Thus, Boehringer Ingelheim is among Austria’s most research intensive pharmaceutical companies. The Regional Center Vienna generated net sales of EUR 760.2 million in the business year 2015 and employed 3,403 employees in the Central and Eastern European region, 1,501 of whom are in Austria.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 2. Mittelstandsforum Nordrhein-Westfalen

    28.06.2017, Düsseldorf, Germany

  • Meet us at „Russia-Europe: Cooperation without frontiers”

    29. – 30.06.2017, Moscow, Russia

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These
features are particularly important for a research-based company such as
Boehringer Ingelheim. Furthermore, Vienna is a city with a good research
infrastructure and a high quality of life, and is thus also an interesting place
for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

Austria on the verge of entering the top ranks of innovators: European Innovation Scoreboard 2017 shows leap to 7th place

“Austria is on the verge of entering the top ranks in Europe with respect to innovation. In only two years, we improved from 11th to 7th place, which is the second best results every achieved in the history of the European Innovation Scorecard. This shows that we are on the path to success, and that our measures and projects such as increasing R&D investments or our open innovation strategy are beginning to have an impact”, says Harald Mahrer, Federal Minister of Science, Research and Economy, commenting on the European Innovation Scorecard 2017 published by the European Commission.

Research premium: added impetus to Research Location Austria

One positive signal for research companies based in Austria occurred in 2016: the increase in the research premium from 10% to 12% was already an important measure designed to strengthen the domestic research landscape.

More news All blog posts